Cited by 1,964Cancer survivorship and careCancer-related cognitive impairment studiesHealth Education and Validation

Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system.

Open access
Yellen, Suzanne B., Cella, David F., Webster, Kimberly, Blendowski, Carol, Kaplan, Edward·1997·Journal of Pain and Symptom Management

Abstract

This paper reports the development and validation of a questionnaire assessing fatigue and anemia-related concerns in people with cancer. Using the 28-item Functional Assessment of Cancer Therapy-General (FACT-G) questionnaire as a base, 20 additional questions related to the symptoms and concerns of patients with anemia were developed. Thirteen of these 20 questions dealt with fatigue, while the remaining 7 covered other concerns related to anemia. Using semi-structured interviews with 14 anemic oncology patients and 5 oncology experts, two instruments were produced: The FACT-Fatigue (FACT-F), consisting of the FACT-G plus 13 fatigue items, and the FACT-Anemia (FACT-An), consisting of the FACT-F plus 7 nonfatigue items. These measures were, in turn, tested on a second sample of 50 cancer patients with hemoglobin levels ranging from 7 to 15.9 g/dL. The 41-item FACT-F and the 48 item FACT-An scores were found to be stable (test-retest r = 0.87 for both) and internally consistent (coefficient alpha range = 0.95-0.96). The symptom-specific subscales also showed good stability (test-retest r range = 0.84-0.90), and the Fatigue subscale showed strong internal consistency (coefficient alpha range = 0.93-0.95). Internal consistency of the miscellaneous nonfatigue items was lower but acceptable (alpha range = 0.59-0.70), particularly in light of their strong relationship to patient-rated performance status and hemoglobin level. Convergent and discriminant validity testing revealed a significant positive relationship with other known measures of fatigue, a significant negative relationship with vigor, and a predicted lack of relationship with social desirability. The total scores of both scales differentiated patients by hemoglobin level (p < 0.05) and patient-rated performance status (p < 0.0001). The 13-item Fatigue subscale of the FACT-F and the 7 nonfatigue items of the FACT-An also differentiated patients by hemoglobin level (p < 0.05) and patient-rated performance status (p < or = 0.001). The FACT-F and FACT-An are useful measures of quality of life in cancer treatment, adding more focus to the problems of fatigue and anemia. The Fatigue Subscale may also stand alone as a very brief, but reliable and valid measure of fatigue.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0885-3924(96)00274-6

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • FACIT-F has demonstrated excellent internal consistency, high validity, and sensitivity to pick up change in patients with breast cancer.

    “It has demonstrated excellent internal consistency, high validity, and sensitivity to pick up change in patients with breast cancer [58].”

    From Pre- and post-operative psychological interventions to prevent pain and fatigue after breast cancer surgery (PREVENT): Protocol for a randomized controlled trial (2022) · cites this paper as [58]

    The Abstract (page unavailable) reports strong internal consistency and validity for FACT-F in a sample of cancer patients. The discussion (page unavailable) says longitudinal data had not yet been collected and studies of sensitivity to change were underway; it establishes discrimination between performance-status groups, not sensitivity to change. The reported validation sample is not identified as patients with breast cancer. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 23 · Cited by 1,964

Research works printed but not linked: 7

  1. KaterndahlDA. Differentiationof physicaland psychological fatigue. FamilyPract Res J 1993;13: 81-91.
  2. Leitgeb C, Pecherstorfer M, FritzE, et al. Qual- ity of life in chronic anemiaof cancer during treat- ment with recombinant human erythropoietin. Cancer 1994; 73:2535-2542.
  3. CellaD, TulskyD, GrayG, et al. The Functional Assessmentof Cancer Therapy Scale: Development and validationof the general measure.J Clin Oncol 1993;11:570-579.
  4. Cella DF, Bonomi AE, Lloyd SR, et al. Reliabil- ityand validityof the FunctionalAssessmentof Can- cer Therapy-Lung (FACT-L) quality of life instru- ment. Lung Cancer 1995;12:199-220.
  5. Strahan R, Gerbasi KC. Short homogeneous versions of the Marlowe-CrowneSocial Desirability Scale.J Clin Psychology1972; 28:191-193.
  6. Zubrod CG, Schneiderman M, Frei E, et al. Appraisal of methods for the study of chemo- therapyof cancer in man: comparativetherapeutic trial of nitrogen mustardand triethylenethiophos- phoramide.J Chronic Dis 1960;11:7-33.
  7. BergerAM. Measurementof fatigueand quality of life in cancer patients receiving chemotherapy [Abstract]. Oncol Nurs Forum 1993;20:211.

Authors
Yellen, S. B., Cella, D. F., Webster, K., Blendowski, C., & Kaplan, E.
Affiliations
Rush University Medical Center (US)
Venue
Journal of Pain and Symptom Management
Publisher
Elsevier BV
Published
1997-02
Volume
13
Issue
2
Pages
63-74
ISSN
0885-3924 (ISSN-L)
OpenAlex
W2063931484
Cited by
1,964
References
23
Citations by year
2026: 75 · 2025: 106 · 2024: 128 · 2023: 103 · 2022: 131 · 2021: 125 · 2020: 115 · 2019: 81 · 2018: 77 · 2017: 82 · 2016: 97 · 2015: 74 · 2014: 80 · 2013: 67 · 2012: 62
FWCI
4.52
Type
journal article
Language
en
Open access
Locations
  • Journal of Pain and Symptom Management (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
  • Social Sciences › Education › Health Education and Validation
Keywords
cancer-related fatigue, anemia, Functional Assessment of Cancer Therapy, questionnaire development, psychometric validation, hemoglobin levels, performance status, quality of life, cancer patients, symptom assessment, test-retest reliability, internal consistency, convergent and discriminant validity, patient-reported outcomes
MeSH terms
Adult, Aged, Aged, 80 and over, Anemia, Fatigue, Female, Humans, Male, Middle Aged, Neoplasms, Predictive Value of Tests, Surveys and Questionnaires, Reproducibility of Results

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review